Summary
Shan Andrews is a Ph.D.-trained genetic epidemiologist and Principal Scientist leading computational biology and human genetics at Denali Therapeutics, with 11 years of experience translating large-scale genomic data (GWAS, WES, WGS) into drug targets, biomarkers, and genetically defined patient cohorts. He bridges human genetics, functional genomics (including CRISPR screens and QTL analyses), and collaborative biology to generate mechanistic insight for neurodegenerative diseases such as Parkinson’s and Alzheimer’s. At Denali he has progressed through roles from scientist to lab leader, shaping genetics strategies across discovery and development. Trained at Johns Hopkins and with a chemical engineering background from the University of Delaware, he combines quantitative rigor with experimental context to de-risk target selection in complex disease programs.
11 years of coding experience
5 years of employment as a software developer
Bachelor of Science - BS, Chemical Engineering, Bachelor of Science - BS, Chemical Engineering at University of Delaware
Doctor of Philosophy - PhD, Genetic Epidemiology, Doctor of Philosophy - PhD, Genetic Epidemiology at Johns Hopkins Bloomberg School of Public Health